PAMEX pramipexole dihydrochloride 0.125 mg tablets blister pack

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Toimeaine:

pramipexole dihydrochloride monohydrate, Quantity: 0.125 mg

Saadav alates:

Arrotex Pharmaceuticals Pty Ltd

INN (Rahvusvaheline Nimetus):

pramipexole dihydrochloride monohydrate

Ravimvorm:

Tablet, uncoated

Koostis:

Excipient Ingredients: silicon dioxide; pregelatinised maize starch; povidone; mannitol; magnesium stearate

Manustamisviis:

Oral

Ühikuid pakis:

10, 30, 100

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

Pramipexole tablets are indicated for:,-the treatment of signs and symptoms of idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa.,-the symptomatic treatment of primary Restless Legs Syndrome.

Toote kokkuvõte:

Visual Identification: White, circular, flat, beveled edged uncoated tablets debossed with 'CL' on one side and '2' on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Volitamisolek:

Licence status A

Loa andmise kuupäev:

2014-09-23